Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
Clinical trial NCT03575637 · UNKNOWN
Trial details
- NCT number
- NCT03575637
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2021-05-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.